Prestige Consumer Healthcare
PBH
#3940
Rank
A$4.50 B
Marketcap
A$91.56
Share price
1.27%
Change (1 day)
-29.97%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$6.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$6.11. In 2024 the company made an earnings per share (EPS) of A$6.47 an increase over its 2023 EPS that were of A-$2.42.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$6.36-1.82%
2024A$6.47-367.08%
2023A-$2.42-138.33%
2022A$6.3211.7%
2021A$5.6613.6%
2020A$4.98-651.67%
2019A-$0.90-148.78%
2018A$1.85-83.29%
2017A$11.08437.23%
2016A$2.06-34.13%
2015A$3.1352.94%
2014A$2.05-8.11%
2013A$2.23
2011A$1.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
A$5.41-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$2.59-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
A-$44.59-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.72 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.84-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$11.08 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
A$10.58 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$0.60-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$9.65 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.13 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA